Free Practice Questions for Iran Specialty Board Dermatology
Exam-style questions and explanations by OpenExamPrep.
Loading practice questions...
Explore More Iran Medical Specialty Boards (دانشنامه تخصصی پزشکی / بورد تخصصی)
Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.
Key Facts: Iran Specialty Board Dermatology Exam
150
Total multiple-choice questions on the national written board certification examination
Secretariat for the Council for Medical and Specialized Education Guidelines
70% (105/150)
Minimum passing score required in the written exam to advance to the clinical OSCE
Sanjesh Pezeshki Specialty Board Examination Regulations
210 min
Total written examination duration, providing approximately 84 seconds per clinical question
Sanjesh Pezeshki Examination Administration Procedures
0
Negative marking: incorrect answers receive zero points without penalty
Iranian Medical Specialty Board Examination Rules
2 Stages
Examination structure: Stage 1 Written MCQ followed by Stage 2 Practical Clinical OSCE
Council for Medical and Specialized Education
The Iranian Dermatology Specialty Board Exam is a rigorous two-stage certification process administered by Sanjesh Pezeshki. Candidates must first achieve at least 70% (105/150) on the 240-minute written MCQ exam without negative marking to advance to the multi-station clinical OSCE and dermatopathology oral examination.
Sample Iran Specialty Board Dermatology Practice Questions
Try these sample questions to review concepts for the Iran Specialty Board Dermatology exam. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.
1A 38-year-old patient presents with well-demarcated erythematous plaques covered by silvery-white scales on the extensor surfaces of the elbows and knees. Which of the following cytokines produced by dendritic cells is primarily responsible for driving the differentiation and expansion of pathogenic Th17 cells in this condition?
2A 42-year-old woman develops intensely pruritic, violaceous, polygonal flat-topped papules on the flexor wrists. Oral examination shows a lacy reticular white pattern on the bilateral buccal mucosa. Which of the following histological features is most characteristic of this disorder on punch biopsy?
3A 26-year-old man presents with an acute eruption of multiple small (2 to 8 mm) teardrop-shaped erythematous scaly papules over his trunk and proximal extremities 2 weeks after recovering from a febrile pharyngitis. Which of the following is the most appropriate initial therapy for this patient?
4A 48-year-old male with poorly controlled plaque psoriasis develops fever, leukocytosis, and sudden widespread eruption of sheets of sterile non-follicular pustules coalescing into lakes of pus on background fiery erythema shortly after abrupt tapering of oral dexamethasone. Which of the following mutations is most frequently implicated in the familial forms of this life-threatening condition?
5Which of the following biologic agents is a fully human IgG1 monoclonal antibody that selectively binds to interleukin-17A (IL-17A) and is approved for moderate-to-severe plaque psoriasis and psoriatic arthritis?
6A 55-year-old woman presents with cicatricial alopecia of the crown and vertex. Examination reveals perifollicular erythema, follicular hyperkeratosis, and loss of follicular ostia. A scalp biopsy demonstrates a lichenoid lymphocytic infiltrate concentrated around the infundibulum and isthmus with concentric lamellar perifollicular fibroplasia. What is the most accurate diagnosis?
7A 5-year-old boy has a long-standing history of xerosis, severe pruritus, and recurrent lichenified eczematous plaques involving the antecubital and popliteal fossae. Laboratory evaluation reveals peripheral blood eosinophilia and markedly elevated serum IgE. Which of the following epidermal barrier proteins is most consistently deficient in this patient's condition?
8A 28-year-old nurse develops acute pruritic vesicles and erythematous scaling on the dorsum of both hands. Patch testing shows a 3+ vesicular reaction to nickel sulfate and a 2+ reaction to thiuram mix. Which of the following immunologic mechanisms mediates this positive patch test response?
9A 60-year-old male presents with orange-red follicular papules that have coalesced into large plaques covering his trunk and extremities, interspersed with well-demarcated islands of completely normal skin ('islands of sparing'). He also exhibits prominent waxy orange-red palmoplantar keratoderma. Which of the following dermatoses is the most likely diagnosis?
10A 34-year-old woman presents with recurrent, painful, tender erythematous nodules on the pretibial aspects of both lower legs. She has no ulceration. A deep incisional biopsy reveals a septal panniculitis without primary vasculitis, featuring Meischer radial granulomas. Which of the following is the most appropriate diagnosis?
About the Iran Specialty Board Dermatology Exam
The Iranian Medical Specialty Board Examination in Dermatology (آزمون دانشنامه تخصصی بیماریهای پوست - commonly known as 'Board-e Takhasosi-e Poost' or 'Daneshnameh Poost') is the highest professional certification examination in clinical dermatology, dermatopathology, venereology, and cutaneous surgery in the Islamic Republic of Iran. Administered annually by the Secretariat for the Council for Medical and Specialized Education in partnership with the National Center for Health Assessment (مرکز سنجش آموزش پزشکی - Sanjesh Pezeshki), passing this rigorous two-stage examination confers full Board Certification (دانشنامه تخصصی), qualifying dermatologists for academic faculty appointments, subspecialty fellowship training, and independent specialist leadership. The curriculum and written examination are based primarily on international gold-standard reference treatises designated by the national board board examining committee: Bolognia's Dermatology and Fitzpatrick's Dermatology in General Medicine, supplemented by national clinical guidelines for endemic conditions such as Old World leishmaniasis and regional pemphigus protocols. The written examination tests 152 questions across six comprehensive domains: Inflammatory, Papulosquamous & Eczematous Dermatoses (~20%), Cutaneous Infections, Infestations & Endemic Leishmaniasis (~18%), Autoimmune Bullous Diseases & Connective Tissue Diseases (~18%), Dermatopathology, Melanocytic Lesions & Cutaneous Oncology (~18%), Dermatologic Surgery, Laser, Phototherapy & Cosmeceuticals (~14%), and Pediatric & Genodermatoses, Drug Reactions & Systemic Manifestations (~12%). This practice question bank is an independent English-language MCQ study adaptation authored by OpenExamPrep. It contains 100 board-caliber clinical scenarios featuring rigorous diagnostic rationales and comprehensive distractor analyses to prepare dermatology residents and international candidates for advanced board-level mastery. The official Iranian examination is delivered in Persian; this resource is an independent educational adaptation and is neither an official translation nor endorsed by Sanjesh Pezeshki.
Exam sponsor: Council for Medical and Specialized Education & National Center for Health Assessment (Sanjesh Pezeshki / مرکز سنجش آموزش پزشکی). The requirements and fees below concern the certification or admission exam, separate from our free practice resources.
Assessment
The Iranian Specialty Board Examination in Dermatology is administered annually in late summer (Shahrivar / September) at central university assessment facilities in Tehran under the auspices of the Secretariat for the Council for Medical and Specialized Education and Sanjesh Pezeshki. The certification consists of two mandatory stages: Stage 1 is the Written Board Examination comprising 152 four-option multiple-choice questions administered over a single 240-minute session (no negative marking; passing cut score is 70%, or 105/150). Candidates who satisfy this threshold qualify for Stage 2, the Practical/Clinical Board Examination (آزمون شفاهی و ساختارمند / OSCE), which assesses clinical slide interpretation, dermatopathology microscopic spot-diagnosis, dermatologic surgical planning, and standardized patient case management.
Time Limit
240 minutes
Passing Score
70% of the written total (105 of 150 points)
Exam / Certification Fees
Set annually by the Ministry of Health and Medical Education, payable online via sanjeshp.ir during official board candidacy registration
Exam sponsor websiteFees, eligibility, and exam policies can change. Confirm them with the exam sponsor before applying or paying.
Our practice resources: topics covered
We aim to reflect publicly available exam outlines and topic information in our study resources. Coverage, format, and difficulty may differ from the actual exam, and we cannot guarantee that every detail is accurate or current. Confirm exam requirements, fees, and policies with the official exam sponsor.
Inflammatory, Papulosquamous & Eczematous Dermatoses
Psoriasis vulgaris, guttate, erythrodermic, and generalized pustular psoriasis (GPP/IL-36 receptor antagonist pathway); biologic mechanisms (anti-TNF, IL-17 inhibitors, IL-23 p19 antagonists); lichen planus variants (classic, oral, lichen planopilaris, bullous); atopic dermatitis pathogenesis and targeted therapies (dupilumab, JAK inhibitors); allergic and irritant contact dermatitis; pityriasis rubra pilaris; erythema annulare centrifugum; and neutrophilic dermatoses (Sweet syndrome, pyoderma gangrenosum).
Cutaneous Infections, Infestations & Endemic Leishmaniasis
Epidemiology, clinical morphology, diagnosis, and treatment of Old World cutaneous leishmaniasis (Leishmania tropica, Leishmania major); meglumine antimoniate (Glucantime) systemics and intralesional protocols, cryotherapy, and thermotherapy; deep and subcutaneous mycoses (mycetoma, chromoblastomycosis, sporotrichosis); leprosy (Hansen disease classification, Ridley-Jopling spectrum, multidrug therapy, lepra reactions); cutaneous tuberculosis; herpesviridae; atypical mycobacteria; and resistant scabies management.
Autoimmune Bullous Diseases & Connective Tissue Diseases
Pemphigus vulgaris (Dsg3 and Dsg1 autoantibodies, first-line rituximab protocols, desmoglein ELISA monitoring), pemphigus foliaceus, paraneoplastic pemphigus, bullous pemphigoid (BP180 NC16A domain), mucous membrane pemphigoid, epidermolysis bullosa acquisita, dermatitis herpetiformis, systemic lupus erythematosus (subacute cutaneous LE, discoid LE), systemic sclerosis and morphea, dermatomyositis (myositis-specific antibodies, malignancy screening), and relapsing polychondritis.
Dermatopathology, Melanocytic Lesions & Cutaneous Oncology
Dermatopathology algorithmic approaches (interface, spongiotic, psoriasiform, granulomatous, and vasculitic patterns); immunohistochemical markers (Melan-A, SOX10, S100, CK20, Ber-EP4, CD10); melanoma subtypes (superficial spreading, nodular, lentigo maligna, acral lentiginous), Breslow depth, sentinel lymph node biopsy guidelines; basal cell carcinoma variants; squamous cell carcinoma and keratoacanthoma; cutaneous T-cell lymphoma (mycosis fungoides stages, Sézary syndrome); and Merkel cell carcinoma.
Dermatologic Surgery, Laser, Phototherapy & Cosmeceuticals
Head and neck surgical anatomy, dangerous nerve zones (facial nerve branches), tumescent local anesthesia, flap dynamics (advancement, rotation, transposition flaps), full-thickness and split-thickness skin grafts, Mohs micrographic surgery tissue processing, laser physics (selective photothermolysis, pulse duration, wavelength selection), narrowband UVB vs. PUVA protocols, chemical resurfacing depths, and botulinum toxin and soft-tissue filler complications.
Pediatric & Genodermatoses, Drug Reactions & Systemic Manifestations
Genodermatoses (ichthyosis vulgaris, X-linked ichthyosis, lamellar ichthyosis, epidermolytic ichthyosis), epidermolysis bullosa subtypes (simplex, junctional, dystrophic), tuberous sclerosis complex, neurofibromatosis type 1, severe cutaneous adverse reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis, DRESS syndrome, AGEP), cutaneous signs of systemic disease (necrolytic migratory erythema, calciphylaxis, pyoderma gangrenosum), and mastocytosis.
Preparing for the Iran Specialty Board Dermatology Exam
What You Need to Know
- Passing score: 70% of the written total (105 of 150 points)
- Assessment: The Iranian Specialty Board Examination in Dermatology is administered annually in late summer (Shahrivar / September) at central university assessment facilities in Tehran under the auspices of the Secretariat for the Council for Medical and Specialized Education and Sanjesh Pezeshki. The certification consists of two mandatory stages: Stage 1 is the Written Board Examination comprising 152 four-option multiple-choice questions administered over a single 240-minute session (no negative marking; passing cut score is 70%, or 105/150). Candidates who satisfy this threshold qualify for Stage 2, the Practical/Clinical Board Examination (آزمون شفاهی و ساختارمند / OSCE), which assesses clinical slide interpretation, dermatopathology microscopic spot-diagnosis, dermatologic surgical planning, and standardized patient case management.
- Time limit: 240 minutes
- Exam / certification fees: Set annually by the Ministry of Health and Medical Education, payable online via sanjeshp.ir during official board candidacy registration Official sources
Using Our Practice Resources
- Work through all 100 available questions
- Review every answer and explanation
- Track weak areas and revisit them
- Use our AI tutor for tough concepts
Iran Specialty Board Dermatology: Suggested Study Strategy
Frequently Asked Questions
What is the Iranian Specialty Board Examination in Dermatology (Daneshnameh Takhasosi Poost)?
The Iranian Specialty Board Examination in Dermatology (آزمون دانشنامه تخصصی بیماریهای پوست) is the definitive national certifying examination administered by the Secretariat for the Council for Medical and Specialized Education under the Ministry of Health and Medical Education (MOHME) through Sanjesh Pezeshki. Successful completion of both the written and clinical components certifies candidates as board-certified dermatologists, entitling them to practice as medical specialists, pursue academic faculty appointments, and enter subspecialty fellowships.
What is the difference between the Certification Exam (Daneshnameh / Board) and the Promotion Exam (Govahi / Arzyabi)?
In the Iranian residency education system, resident physicians take annual Promotion Examinations (آزمون ارتقاء) to progress from year to year (PGY-1 through PGY-4). At the conclusion of their final year, residents sit for the Exit Certification Exam (گواهینامه تخصصی), which allows them to fulfill compulsory public health service as specialists. The National Board Examination (دانشنامه تخصصی / بورد), taken concurrently or sequentially, is an optional higher credential required for academic faculty posts, university teaching hospital privileges, and fellowship training.
What is the structure of the written examination, and what is the passing threshold?
The written board examination consists of 152 four-option multiple-choice questions administered over 240 minutes (1.6 minutes per question). There is no negative marking for incorrect choices. Examinees must score at least 70% (105 points out of a written total of 150) to pass the written stage and qualify for the clinical OSCE examination.
What does the second stage (Clinical OSCE / Practical Exam) entail?
The practical examination (آزمون شفاهی و ساختارمند / OSCE) typically features 10 to 14 objective structured stations. These stations assess real-world diagnostic slide interpretation, multihead dermatopathology microscope review, cutaneous surgical flap planning on models, laser parameters selection, patient communication, and management of acute dermatologic emergencies.
Which textbooks and references are the primary sources for the Iranian Dermatology Board?
The national examination board designates Bolognia's Dermatology (current edition) and Fitzpatrick's Dermatology in General Medicine as the primary comprehensive references. In addition, national protocols and guidelines published by the Ministry of Health on endemic disorders—notably cutaneous and mucocutaneous leishmaniasis and pemphigus vulgaris management—are heavily weighted.
Is this OpenExamPrep question bank an official Sanjesh Pezeshki study tool?
No. This question bank is an independent English-language multiple-choice practice adaptation authored by OpenExamPrep for conceptual review and board exam preparation. The official Iranian specialty board examination is administered in Persian by Sanjesh Pezeshki and the Council for Medical and Specialized Education. This resource is not affiliated with, endorsed by, or an official translation of Sanjesh Pezeshki or the Iranian Ministry of Health and Medical Education.